1 Version 1.0 7th of January 2020

Request for Quotation (RFQ) for printing ofcardstockmedicationsleeves KNCVTuberculosisFoundationKNCVTuberculosisFoundation(KNCV)isaninternationalnon-profitorganizationdedicatedtothefightagainsttuberculosis(TB),stillthesecondmostdeadlyinfectiousdiseaseintheworld.KNCVisaninternationalcenterofexpertiseforTBcontrolthatpromoteseffective,efficient,innovativeandsustainableTBcontrolstrategiesin a national and international context. We are an organization of passionate TB professionals, includingdoctors, researchers, training experts, nurses and epidemiologists. We aim to stop the spread of theworldwideepidemicofTBandtopreventthefurtherspreadofdrug-resistantTB.TheASCENTprojectASCENT (Adherence Support Coalition to End TB) is a Unitaid funded project to help patients successfullycompletetheircourseoftreatmentthroughtheuseofdigitaladherencetechnologiesanddata-drivensupportinterventions,utilizingtoolssuchassmartpillboxesandother innovations.TheprojectwillbeimplementedfromJuly2019untilDecember2022andaimstoreachnearly70.000patientsinUkraine,Ethiopia,Tanzania,SouthAfricaand thePhilippines. Thesedigital adherence technologiesempowerpatients to take theirdailymedicationatatimeandplacethatsuitsthembest.Additionallytheyprovidereal-timeinformationtotheTBdoctorornurse,helping todetermine themostappropriate treatmentapproach foreach individualpatientandbyenablingfocusedeffortsonthosepatientsthatrequireextrasupport.

ObjectiveofRFQToprintcardstockmedicationsleevesusedforrepackingofexistingFixed-DoseCombination(FDC)antibioticmedication blister packs for Tuberculosis (TB) inmultiple or selected countries that implement theASCENTproject.

TimelineFirstcontractualperiodwillbefrom1stofMarch2020–1stofMarch2021withthepossibilitytoextent.Thecandidateshouldbecapabletostartactivitieswithin1monthaftercontractsigning.

PublishedThis RFQ is published from 13th of January to 31st of January 2020 on the ASCENT(http://www.digitaladherence.org) and KNCV Tuberculosis website(https://www.kncvtbc.org/en/downloads/).Reviewandselectionwilltakeplacefrom1stofFebruary–14thofFebruary2020.

SubmissionProposalsshouldbesubmittedviaascent@kncvtbc.organdmustbereceivedby11:59CETon31stofJanuary2020.Proposalsreceivedafterthisdateandtimeshallbe invalidandwillbeblockedfromreview.ProposalsshouldbesubmittedinEnglishandeachinterestedpartyshallsubmitonlyonequotation.Thequotationneedstoincludethefollowingdocuments:

1. CompletedRequirementsdocument2. CompletedBudgettable

SelectionSelection of the candidate(s) will be based upon independent assessment of the proposals by a reviewcommittee consisting of in-country and external specialists. KNCVwill evaluate all quotations based on thefollowingcriteria:1. Overallsuitability:proposedsolutionsmustmeetthescopeandbepresentedinaclearandorganized

manner.2. Organizationalexperience:Organizationswillbeevaluatedontheirexperiencerelatedtothescopeof

thisRFQ.

2 Version 1.0 7th of January 2020

3. Valueandcost:Organizationswillbeevaluatedonthecostoftheirsolution(s)basedontheworktobeperformedinaccordancewiththescopeofthisproject.

QuestionsandcontactKNCV reserves the right to request further information during the RFQ process. Questions regardingrequirementsdescribedinthisRFQmustbedirectedinwritingviaemailtoascent@kncvtbc.orgbefore24thofJanuary2020.Responses toquestionsand/orclarificationsoriginating fromsuchquestions that improve thequalityof theRFQwillbepublishedonthesamewebsites.ToensureyoureceivemodificationstotheRFQ,sendanemailtoascent@kncvtbc.orgtobeputonthedistributionlist.IssuanceofthisquotationdoesnotinanywayconstituteacommitmentonthepartoftheASCENTnordoesitcommittopayforcostsincurredinthepreparationandsubmissionofproposal.

3 Version 1.0 7th of January 2020

BackgroundIn this section, abackgroundof the cardstockmedication sleeve, its utilizationand specifications related tomedicationsleevetypesanddesignisprovided.BackgroundThe cardstock medication sleeve is part of a digitaladherence technology thatusescustomcardstocksleevestorepackexistingFixed-DoseCombination(FDC)antibioticmedication blister packs for Tuberculosis (TB) treatment.Afterrepacking,thesecardstocksleevesprovideaseriesofunpredictable hidden toll-free phone numbers or SMScodesthatarerevealedeachtimeapatientremovestheirpillsfortheday.ProductspecificationsThemedicationsleeveisinitiallyasinglelargesheetofpaper(1)thatfoldsoverwiththetworemainingedges(A and B) that have covers which should be folded over and sealed. The medication sleeve looks like anenvelopenow(2)withthelastflap(C)opensothatamedicationblistercanslideinata latermoment.Thislastsideispreferablyfixedwithadouble-sidedtape.

MedicationsleevedesignOutsideOne side of the medication sleeve has 28 openings for the elevated pill compartments present in themedicationblisterpack.Theothersidehascoverswithperforationstoallowpillstobedispensed.Coversarepre-cutalongthetwolongedges,foldedatoneoftheshortedges,andperforatedalongtheremainingshortedge.Itisessentialthatthesecoversdonotopenbeforemedicationispressedoutfromtheblisterpack.InsideOntheinnerside,codesareprintedon14ofthe28flaps.Morespecifically,codesareprintedonthe(2ndand4thcoverinthe1stcolumn,1stand3rdcoverinthe2ndcolumn,2ndand4thcoverinthe3rdcolumn,1stand3rdcoverinthe4thcolumn,2ndand4thcoverinthe5thcolumn,1stand3rdcoverinthe6thcolumn,2ndand4thcoverinthe7thcolumn).SequenceversionsEachmedicationsleevetype(seeFigure2examples)willhave50sequenceversions,eachwithdifferentcodesequences.Oneachversion,thecodesshouldbeprintedasperprovidedsequence.Eachdifferentsequenceversion per type of medication sleeve can be printed separately and then shuffled before distribution.Example: If the total required quantity of a medication sleeve type is 1,000, it means that we expect 20medicationsleevesperuniquesequenceversion(1,000/50=20).

Figure 1. Overview of medication sleeve interaction

Figure 2 examples of medication sleeves (front and back)

4 Version 1.0 7th of January 2020

Medicationsleevetypes:ExampletechnicaldocumentandtemplateAvarietyofmedicationsleevesisusedforTBtreatmentintheASCENTcountries.Aspartofthefinalorder,thefollowingdocumentswillbeprovidedforeachspecificmedicationsleevetypepercountry:1. Keyline Frontandbackartworkforthemedicationsleeve2. Sequence Contains50replicationsofthemedicationsleevedesign(frontandback),eachwith

differentsequences3. Die Specifiesthedesignrequiredforbuildingthediecut(measurements,fullcuts,

perforationsetc.)Examplesofthesedocumentscanbeaccessedvia https://www.kncvtbc.org/uploaded/2020/01/ASCENT-Medication-Sleeve-Example.zip

s

Figure 3 examples medication sleeves (inside and outside)

5 Version 1.0 7th of January 2020

RequirementsdocumentIn this section, technical, organizational and budget requirements of the RFQ are described. Interestedcandidatesshouldprovideapoint-by-pointresponsetoeachrequirement.Thefollowingpagescanbeusedforanswersormakesurethattherespectivequestionnumberismentionedwhenusingadifferentdocument. TechnicalCountryorinternationalbidSelectthecountryorcountriesforwhichyoucanperformtheproposedwork:

o Ethiopiao Tanzaniao SouthAfricao Philippines

Die1 Reviewtheexampledie-cuttemplateanddescribewhetherthistemplateisfitforusetoproduceadie.If

not,explainrequiredchanges.2 Describeyourexperiencewith creationofadie in-house. Ifnot, explainwhere the requireddiewill be

produced.3 Providetheestimatedtime(indays)toproduceadie.Thisshouldbesplitintoproduction,testsandtime

neededforanyadjustmentsafterproductionpriortoprinting.4 Explaintowhatextentadjustmentstothediecanbeperformed(e.g.refiningperforationsperpillcover),

wheretheseadjustmentswilltakeplaceandprovideestimatedtime.5 Provide costs to complete the production of the die. Also describewhether theASCENT project or the

candidatehasownershipoverthedie.6 Incasethatthediewillnotbeproduced in-house,explainwhetheradiethatwasproducedatanother

manufacturercanbeused.Printing1 Explainpapertypesavailableandrecommended(e.g.280gsmaqueouscoatedpaper)forthemedication

sleeve.2 Provideabriefdescriptiononhowthemedicationsleevesarecutaccordingtothedietemplate.3 Provideabriefdescriptiononhowthemedicationsleevesaregluedandfolded.4 Provideabriefdescriptiononhowthedouble-sidedtapeisappliedtothemedicationsleeve.

Orderprocessandqualitycontrol1 Provideabriefdescriptionaboutyourorderprocess.2 Providea(brief)descriptiononyourqualitycontrolmechanismsfromreceivingourorderuntilshipment.Organizational

1 Describe your infrastructure, including type of printers and other machines that you will use to

successfullyperformtheproposedwork.2 Provideproofoftheexpertise,capacityandexperienceinthesuccessfulexecutionofcomparableworks.BudgetAllquotationsmustincludeproposedcoststocompletethetasksdescribedinthetechnicalspecificationsandtechnical requirements.Thequantitiesofcardstockmedicationsleeves thatwillbeorderedpercountrywillrange from10.000to150.000perbatch. Interestedcandidatesare thereforerequestedto fill in thebudgettablebelow.

6 Version 1.0 7th of January 2020

• In casemultiple countries are selected, shipping costs frommanufacturer to the capital city of thereceivingcountryshouldbeadded in theShippingcostscolumn(s)with incotermsDeliveryatPlaceUnloaded.

• Incaseofin-countrymanufacturing,localshippingcostsfrommanufacturertothecapitalcityshouldbeaddedintheShippingcostscolumn.

Batch Quantity Production

costspersleeve(inUSD)

Weight(inkg)perbatch

ShippingcostsperbatchThe

Philippines

Shippingcostsperbatch

Ethiopia

Shippingcostsperbatch

Tanzania

Shippingcostsperbatch

SouthAfrica

1 10.000 2 25.000 3 50.000 4 100.000 5 150.000